Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,378 | 483 | 80.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,251 | 4 | 8.8% |
| Consulting Fee | $1,083 | 4 | 7.6% |
| Honoraria | $400.00 | 1 | 2.8% |
| Education | $104.99 | 2 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $2,217 | 139 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $1,473 | 13 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $1,155 | 42 | $0 (2024) |
| Lilly USA, LLC | $924.34 | 37 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $874.23 | 33 | $0 (2024) |
| ABBVIE INC. | $754.35 | 32 | $0 (2024) |
| GENZYME CORPORATION | $737.01 | 6 | $0 (2023) |
| Amgen Inc. | $718.22 | 21 | $0 (2024) |
| Cepheid | $601.00 | 2 | $0 (2023) |
| LEO Pharma Inc. | $523.45 | 27 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,799 | 54 | Janssen Biotech, Inc. ($452.81) |
| 2023 | $2,209 | 75 | Janssen Biotech, Inc. ($426.66) |
| 2022 | $2,042 | 95 | Janssen Biotech, Inc. ($540.12) |
| 2021 | $1,884 | 47 | GENZYME CORPORATION ($674.00) |
| 2020 | $260.01 | 14 | Janssen Scientific Affairs, LLC ($60.40) |
| 2019 | $1,598 | 65 | Janssen Scientific Affairs, LLC ($475.92) |
| 2018 | $1,888 | 55 | Encore Dermatology Inc. ($413.07) |
| 2017 | $2,536 | 89 | Medimetriks Pharmaceuticals, Inc. ($461.73) |
All Payment Transactions
494 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $120.22 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $113.18 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $8.11 | General |
| Category: Inflammation | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $25.51 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.35 | General |
| Category: Immunology | ||||||
| 10/16/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Dermatology | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Immunology | ||||||
| 10/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $8.94 | General |
| Category: Inflammation | ||||||
| 10/03/2024 | Helsinn Therapeutics (U.S.), Inc. | VALCHLOR (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $37.31 | General |
| Category: Dermatology | ||||||
| 09/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $107.10 | General |
| Category: Immunology | ||||||
| 09/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Immunology | ||||||
| 09/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $33.92 | General |
| Category: Inflammation | ||||||
| 08/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.48 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/20/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $26.38 | General |
| Category: Immunology | ||||||
| 08/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.92 | General |
| Category: Immunology | ||||||
| 08/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Immunology | ||||||
| 07/25/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Oncology | ||||||
| 07/23/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: Dermatology | ||||||
| 07/18/2024 | Helsinn Therapeutics (U.S.), Inc. | VALCHLOR (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: ONCOLOGY | ||||||
| 07/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.01 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 474 | 1,506 | $123,930 | $41,547 |
| 2022 | 7 | 452 | 1,308 | $107,655 | $35,719 |
| 2021 | 8 | 353 | 690 | $70,110 | $26,984 |
| 2020 | 7 | 392 | 917 | $118,913 | $12,815 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 110 | 191 | $28,650 | $12,930 | 45.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 76 | 113 | $25,990 | $9,956 | 38.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 102 | 188 | $30,080 | $7,740 | 25.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 92 | 918 | $22,950 | $4,679 | 20.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 51 | 51 | $8,160 | $2,487 | 30.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 28 | 30 | $5,250 | $2,450 | 46.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $2,850 | $1,304 | 45.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 96 | 150 | $22,500 | $9,818 | 43.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 95 | 164 | $26,240 | $7,029 | 26.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 52 | 72 | $16,560 | $6,608 | 39.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 79 | 787 | $19,675 | $4,050 | 20.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 77 | 77 | $12,320 | $3,559 | 28.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 39 | 44 | $7,700 | $3,524 | 45.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 14 | 14 | $2,660 | $1,133 | 42.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 83 | 113 | $16,950 | $8,144 | 48.0% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 38 | 58 | $13,340 | $5,607 | 42.0% |
| 17000 | Destruction of skin growth | Office | 2021 | 68 | 88 | $14,080 | $3,971 | 28.2% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 53 | 53 | $8,480 | $3,097 | 36.5% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 27 | 28 | $4,900 | $2,385 | 48.7% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 52 | 316 | $7,900 | $1,744 | 22.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 14 | 14 | $2,660 | $1,072 | 40.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 18 | 20 | $1,800 | $965.00 | 53.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 74 | 84 | $16,380 | $3,196 | 19.5% |
| 17000 | Destruction of skin growth | Office | 2020 | 109 | 117 | $35,100 | $2,820 | 8.0% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 42 | 43 | $21,500 | $2,112 | 9.8% |
About Dr. Michael Tomeo, MD
Dr. Michael Tomeo, MD is a Dermatology healthcare provider based in Doylestown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1326046830.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Tomeo, MD has received a total of $14,217 in payments from pharmaceutical and medical device companies, with $1,799 received in 2024. These payments were reported across 494 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($11,378).
As a Medicare-enrolled provider, Tomeo has provided services to 1,671 Medicare beneficiaries, totaling 4,421 services with total Medicare billing of $117,065. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Doylestown, PA
- Active Since 07/08/2005
- Last Updated 11/20/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1326046830
Products in Payments
- TREMFYA (Drug) $1,755
- DUPIXENT (Biological) $1,550
- Tremfya (Drug) $1,325
- ILUMYA (Biological) $718.30
- TALTZ (Drug) $708.70
- Otezla (Drug) $624.02
- ENSTILAR (Drug) $456.45
- Impoyz (Drug) $450.42
- VTAMA (Drug) $408.60
- Neo-Synalar Cream (Drug) $390.35
- EUCRISA (Drug) $344.37
- SKYRIZI (Biological) $286.58
- REMICADE (Biological) $258.36
- VALCHLOR (Drug) $254.19
- DUPIXENT DUPILUMAB INJECTION (Biological) $241.41
- RINVOQ (Biological) $237.72
- STELARA (Biological) $226.91
- Ceracade (Drug) $137.28
- Cimzia (Drug) $123.67
- OPZELURA (Drug) $116.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Doylestown
Dr. Mary Toporcer, M.d, M.D
Dermatology — Payments: $10,610
Shannon Wiedersum, D.o, D.O
Dermatology — Payments: $8,475
Jeffrey Kushner, D.o, D.O
Dermatology — Payments: $7,842
Alison Berk, Pa-C, PA-C
Dermatology — Payments: $3,734
Maya Ponte, M.d, M.D
Dermatology — Payments: $1,813